Autoimmune Hepatitis Differential Panel for Hep-C Patient
Test Code
Clinical Significance
Autoimmune Hepatitis Differential Panel for Hep-C Patient -
This panel may help diagnose or exclude autoimmune hepatitis (AIH) in patients with hepatitis C for the purpose of informing treatment options. This panel includes an antinuclear antibody (ANA) immunofluorescence assay (IFA) screen, performed on human epithelial type 2 (HEp-2) cells, with reflex to titer and pattern; smooth muscle antibody (SMA); liver kidney microsome type 1 (LKM-1) antibody; soluble liver antigen (SLA) antibody; and anti-mitochondrial antibody (AMA) with reflex to titer.
Certain hepatitis C therapies, such as peginterferon and ribavirin, are contraindicated for patients ...
Test Resources
Please visit our Clinical Education Center to stay informed on any future publications, webinars, or other education opportunities.
Test Details
Mitochondrial Antibody with Reflex to Titer
Actin (Smooth Muscle) Antibody (IgG)
Liver Kidney Microsomal (LKM-1) Antibody (IgG)
Soluble Liver Antigen (SLA) Autoantibody
If ANA Screen, IFA is positive, then ANA Titer and Pattern will be performed at an additional charge (CPT code(s): 86039).
If Mitochondrial Antibody Screen is positive, then Mitochondrial Antibody Titer will be performed at an additional charge (CPT code(s): 86381).
Methodology
Reference Range(s)
Alternative Name(s)
Preferred Specimen(s)
Serum - See Collection Instructions
Collection Instructions
Serum: 2 spun serum separator tubes (SST).
Spin and submit one SST at room temperature.
Spin second SST and submit refrigerated.
Transport Container
See Collection Instructions
Transport Temperature
See Collection Instructions
Specimen Stability
- See individual tests
Setup Schedule
Spin and submit one SST at room temperature.
Spin second SST and submit refrigerated.